Efficacy of single low-dose dexamethasone with NEPA for the 168 h prevention of highly or moderately emetogenic chemotherapy
Single low-dose DEX (8 mg) with NEPA safely prevents CINV in high-risk patients during MEC/HEC cycles, offering an alternative to minimize the dose and frequency of DEX.
Authors
- Weijuan Tan (ORCID: https://orcid.org/0000-0002-0454-3980)
- Yiqin Zhang (ORCID: https://orcid.org/0009-0007-3343-6889)
- Huibo Shi (ORCID: https://orcid.org/0000-0003-1555-2062)
- Yuting He (ORCID: https://orcid.org/0000-0001-7133-9501)
- Xiao Li (ORCID: https://orcid.org/0000-0002-8889-9609)
- Fanzhuoran Lou
- Xiubao Ren (ORCID: https://orcid.org/0000-0003-4137-2049)
- Qunbo Lin
- Xintian Huang
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Zhongshan Hospital of Xiamen University (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-09-29
- DOI
- https://doi.org/10.3389/fphar.2025.1622789
- Primary Topic
- Nausea and vomiting management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Xiamen City
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
- Fujian Provincial Health Commission